Molecular Prediction of Response and Survival in NSCLC

Neha Vapiwala, MD
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 14 de noviembre del 2003

Translation for this article does not exist


7 Tips for Giving Smart on #givingtuesday
by Christina Bach, MSW, LCSW, OSW-C
November 25, 2015

Related News

EGFR Level Predicts Survival Benefit of Cetuximab in NSCLC

Nov 7, 2011

Patients with high EGFR expression survive longer if they receive cetuximab in addition to chemo

Imaging Predicts Breast Cancer Response to Chemotherapy

May 24, 2012

Magnetic resonance imaging better than clinical assessment for women undergoing pre-op chemo

Tissue Platinum Concentrations Linked to Response in NSCLC

Aug 15, 2012

Concentration linked to percent reduction in non-small-cell lung tumor size; improved survival